Tuesday Feb 09, 2021

Supply resiliency during unprecedented times

The Coronavirus pandemic reveals how vulnerable the drug supply chain can be. In this episode, we will discuss what frontline pharmacists need to know to ensure essential medications are available and the drug supply remains resilient.


Guest speakers:

Doug Kucera

Associate Vice President

Contract Services, Pharmacy



Mittal Sutaria, PharmD

Vice President

Contract and Program Services, Pharmacy




Gretchen Brummel, PharmD, BCPS

Pharmacy Executive Director

Vizient Center for Pharmacy Practice Excellence


Show Notes:

[01:31] Demand for Propofol for COVID ventilated patients skyrocketed to 272%

[01:52] Private label programs provides resiliency to the market

[02:41] How to strengthen pharmacy supply chain

[03:55] Drug shortage task force objectives

[06:00] Essential Medication Lists

[06:57] Labor cost for managing drug shortages

[08:10] Prioritize Essential Medication List and educate others   

[08:35] Elevate the transparency, accountability and resiliency of the pharmaceutical supply chain  

[10:08] Frontline pharmacist advocacy plays a huge role

[10:45] Ask questions to make sure the solution is in the best interest for your pharmacy


Links | Resources:

Vizient’s Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of propofol as COVID-19 Cases Surged, Click here

Essential Medications for Patient Care, Click here

Drug shortages and labor costs: Measuring a hidden cost of drug shortages on U.S. hospitals, Click here

Essential medications review (November 2020), Click here

Vizient Identifies Essential Medications in Hospitals and Highlights Fragility of the Supply Chain, Click here


Subscribe Today!

Apple Podcasts


Google Podcasts



RSS Feed


Copyright 2024 All rights reserved.

Version: 20230822